- Previous Close
163.30 - Open
163.30 - Bid 163.80 x --
- Ask 164.10 x --
- Day's Range
161.00 - 165.10 - 52 Week Range
54.75 - 169.80 - Volume
107,765 - Avg. Volume
108,968 - Market Cap (intraday)
20.01B - Beta (5Y Monthly) 1.26
- PE Ratio (TTM)
169.28 - EPS (TTM)
0.97 - Earnings Date Oct 23, 2024
- Forward Dividend & Yield 0.50 (0.30%)
- Ex-Dividend Date May 15, 2024
- 1y Target Est
167.75
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
www.add.life2,322
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ALIF-B.ST
View MorePerformance Overview: ALIF-B.ST
Trailing total returns as of 9/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALIF-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALIF-B.ST
View MoreValuation Measures
Market Cap
20.01B
Enterprise Value
25.15B
Trailing P/E
169.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.00
Price/Book (mrq)
3.89
Enterprise Value/Revenue
2.52
Enterprise Value/EBITDA
41.98
Financial Highlights
Profitability and Income Statement
Profit Margin
1.18%
Return on Assets (ttm)
2.38%
Return on Equity (ttm)
2.30%
Revenue (ttm)
9.99B
Net Income Avi to Common (ttm)
118M
Diluted EPS (ttm)
0.97
Balance Sheet and Cash Flow
Total Cash (mrq)
242M
Total Debt/Equity (mrq)
104.63%
Levered Free Cash Flow (ttm)
800M